Panel: Investors’ Amended Complaint Failed To Cure Pleading Deficiencies

Mealey's (June 21, 2022, 1:57 PM EDT) -- NEW YORK — A federal district court did not err in denying shareholders an opportunity to file a proposed second amended complaint (PSAC) in a securities class action against a pharmaceutical...
To view the full article, register now.